Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 30.45
+0.45 (1.50%)
Nov 25, 2025, 1:30 PM CST
Polaris Group Company Description
Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services.
The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications, as well as provides healthcare consulting, staffing, and MDS solutions.
The company was incorporated in 2006 and is based in Grand Cayman, Grand Cayman.
Polaris Group
| Country | Cayman Islands |
| Founded | 2006 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 165 |
| CEO | Jaan-Pyng Hsu |
Contact Details
Address: PO Box 309 Grand Cayman, KY1-1104 Cayman Islands | |
| Phone | 813 886 6500 |
| Website | polaris-group.com |
Stock Details
| Ticker Symbol | 6550 |
| Exchange | Taiwan Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | KYG7171A1085 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jaan-Pyng Hsu | Chief Executive Officer and Chairman of the Board |
| Jack Fitzgibbons | President |
| Ray Wu M.B.A. | Chief Financial Officer |
| Yimingli Gao | Accounting Supervisor |
| Chien-Hsing Chang | Chief Strategy Officer |
| Kevin Wu | Chief Information Security Officer |